{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:44:49Z","timestamp":1787845489084,"version":"build-2784847793"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>\n                    Inflammatory spindle cell PEComa is a rare PEComa variant with rare cases harboring\n                    <jats:italic toggle=\"yes\">YAP1::TFE3<\/jats:italic>\n                    fusion recently reported in the lungs. These tumors share identical\n                    <jats:italic toggle=\"yes\">YAP1::TFE3<\/jats:italic>\n                    fusion breakpoints and overlapping morphology with clear cell stromal tumor of the lung (\n                    <jats:italic toggle=\"yes\">CCST-L<\/jats:italic>\n                    ), but differ by demonstrating a myomelanocytic immunophenotype. We report the first 3 nonvisceral cases of inflammatory spindle cell PEComa with\n                    <jats:italic toggle=\"yes\">YAP1::TFE3<\/jats:italic>\n                    fusion. All occurred in female patients, aged 51 to 76 years, involving the vulva, presacral region, and thigh, and ranged from 3.8 to 5.0\u00a0cm (median: 4.0\u00a0cm). Histologically, all were well circumscribed with a fibrous capsule containing lymphoid cuffs, and were composed of fusiform to plump spindle cells arranged in short fascicles and vaguely storiform patterns, admixed with prominent inflammatory infiltrates. Extensive stromal calcifications, focal necrosis and occasional mitotic figures, including one atypical mitosis, were present in one case. Immunohistochemically, all cases were positive for smooth muscle actin and HMB45, and negative for cytokeratins, ERG, CD31, S100, and ALK. Targeted RNA sequencing identified\n                    <jats:italic toggle=\"yes\">YAP1::TFE3<\/jats:italic>\n                    fusions in all tumors, with 2 showing identical breakpoints to\n                    <jats:italic toggle=\"yes\">CCST-L<\/jats:italic>\n                    (\n                    <jats:italic toggle=\"yes\">YAP1<\/jats:italic>\n                    exon 4\u2013\n                    <jats:italic toggle=\"yes\">TFE3<\/jats:italic>\n                    exon 7), and 1 showing a breakpoint involving\n                    <jats:italic toggle=\"yes\">YAP1<\/jats:italic>\n                    exon 3\u2013\n                    <jats:italic toggle=\"yes\">TFE3<\/jats:italic>\n                    exon 7. We report the first 3 cases of\n                    <jats:italic toggle=\"yes\">YAP1::TFE3<\/jats:italic>\n                    -rearranged, nonvisceral inflammatory spindle cell PEComa occurring in somatic soft tissue sites, expanding the anatomic spectrum of this recently characterized entity. Inflammatory spindle cell PEComa should be considered in the differential diagnosis of spindle cell neoplasms with prominent admixed inflammation.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002509","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:00:07Z","timestamp":1768194007000},"page":"448-454","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Nonvisceral YAP1::TFE3 \u2013Rearranged Inflammatory Spindle Cell PEComa in Somatic Soft Tissue"],"prefix":"10.1097","volume":"50","author":[{"given":"Abdalla","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Fritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1139-2914","authenticated-orcid":false,"given":"Josephine K.","family":"Dermawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"R1-20260316","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/his.15328","article-title":"Inflammatory spindle cell PEComa of the lung with YAP1::TFE3 fusion: a report of two cases and a potential relationship with clear cell stromal tumor","volume":"86","author":"Kojima","year":"2025","journal-title":"Histopathology"},{"key":"R2-20260316","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/PAS.0000000000001719","article-title":"Recurrent YAP1-TFE3 gene fusions in clear cell stromal tumor of the lung","volume":"45","author":"Agaimy","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R3-20260316","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/his.14437","article-title":"YAP1-TFE3 gene fusion variant in clear cell stromal tumor of lung: report of two cases in support of a distinct entity","volume":"79","author":"Dermawan","year":"2021","journal-title":"Histopathology"},{"key":"R4-20260316","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/his.14706","article-title":"Clear cell stromal tumor of the lung with YAP1::TFE3 fusion: four cases including a case with highly aggressive clinical course","volume":"81","author":"Dehner","year":"2022","journal-title":"Histopathology"},{"key":"R5-20260316","doi-asserted-by":"crossref","first-page":"100632","DOI":"10.1016\/j.modpat.2024.100632","article-title":"Clear cell stromal tumor of the lung: clinicopathologic, immunohistochemical, and molecular characterization of eight cases","volume":"38","author":"Odintsov","year":"2025","journal-title":"Mod Pathol"},{"key":"R6-20260316","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13000-023-01304-0","article-title":"Clear cell stromal tumor of the lung with multinucleated giant cells: a report of a case with YAP1-TFE3 fusion","volume":"18","author":"Jak\u0161a","year":"2023","journal-title":"Diagn Pathol"},{"key":"R7-20260316","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.prp.2004.08.001","article-title":"Hepatic angiomyolipoma resembling an inflammatory pseudotumor of the liver. A case report","volume":"200","author":"Kojima","year":"2004","journal-title":"Pathol Res Pract"},{"key":"R8-20260316","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.anndiagpath.2010.03.002","article-title":"Inflammatory angiomyolipomas of the liver: a clinicopathologic and immunohistochemical analysis of 5 cases","volume":"14","author":"Shi","year":"2010","journal-title":"Ann Diagn Pathol"},{"key":"R9-20260316","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1746-1596-7-122","article-title":"Inflammatory angiomyolipoma of the liver: a rare hepatic tumor","volume":"7","author":"Liu","year":"2012","journal-title":"Diagn Pathol"},{"key":"R10-20260316","first-page":"771","article-title":"Inflammatory angiomyolipoma of the liver: an unusual case suggesting relationship to IgG4-related pseudotumor","volume":"6","author":"Agaimy","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"R11-20260316","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1016\/j.clinre.2020.04.005","article-title":"Pooled analysis of hepatic inflammatory angiomyolipoma","volume":"44","author":"Mao","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R12-20260316","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13000-023-01343-7","article-title":"A case report of hepatic angiomyolipoma, inflammatory subtype. Clinico-pathological characterization: a diagnostic challenge","volume":"18","author":"Velasco-Albendea","year":"2023","journal-title":"Diagn Pathol"},{"key":"R13-20260316","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13000-024-01485-2","article-title":"A case of pancreatic PEComa with prominent inflammatory cell infiltration: the inflammatory subtype is a distinct histologic group of PEComa","volume":"19","author":"Tsukita","year":"2024","journal-title":"Diagn Pathol"},{"key":"R14-20260316","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1177\/10668969251323936","article-title":"Perivascular epithelioid cell tumor of the lung with a novel YAP1::TFE3 fusion","volume":"33","author":"MacDonald","year":"2025","journal-title":"Int J Surg Pathol"},{"key":"R15-20260316","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00428-024-04016-y","article-title":"YAP1::TFE3 fusion in a case of malignant TFE3-rearranged PEComa of the lung: expanding the spectrum of pulmonary PEComa-like mesenchymal neoplasms","volume":"486","author":"Hsu","year":"2025","journal-title":"Virchows Arch"},{"key":"R16-20260316","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5858\/arpa.2020-0336-OA","article-title":"Diagnostic utility of a custom 34-gene anchored multiplex PCR-based next-generation sequencing fusion panel for the diagnosis of bone and soft tissue neoplasms with identification of novel usp6 fusion partners in aneurysmal bone cysts","volume":"145","author":"Dermawan","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"R17-20260316","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/PAS.0b013e3181f17ac0","article-title":"A distinctive subset of PEComas harbors TFE3 gene fusions","volume":"34","author":"Argani","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R18-20260316","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/PAS.0000000000000389","article-title":"Dichotomy of genetic abnormalities in PEComas with therapeutic implications","volume":"39","author":"Agaram","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R19-20260316","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/PAS.0000000000000502","article-title":"PSF\/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity","volume":"39","author":"Rao","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R20-20260316","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/PAS.0000000000002218","article-title":"TFE3-rearranged PEComa\/PEComa-like neoplasms: report of 25 new cases expanding the clinicopathologic spectrum and highlighting its association with prior exposure to chemotherapy","volume":"48","author":"Argani","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"R21-20260316","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/gcc.22073","article-title":"Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma","volume":"52","author":"Antonescu","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"R22-20260316","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1038\/s41379-021-00879-7","article-title":"YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases","volume":"34","author":"Dermawan","year":"2021","journal-title":"Mod Pathol"},{"key":"R23-20260316","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.gene.2012.08.025","article-title":"Identification, basic characterization and evolutionary analysis of differentially spliced mRNA isoforms of human YAP1 gene","volume":"509","author":"Gaffney","year":"2012","journal-title":"Gene"},{"key":"R24-20260316","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/gcc.20491","article-title":"EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma","volume":"46","author":"Antonescu","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"R25-20260316","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/01.pas.0000213393.57322.c7","article-title":"Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases","volume":"31","author":"Coffin","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R26-20260316","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/(SICI)1096-9896(199805)185:1<112::AID-PATH54>3.0.CO;2-U","article-title":"Inflammatory leiomyosarcoma may be characterized by specific near-haploid chromosome changes","volume":"185","author":"Dal Cin","year":"1998","journal-title":"J Pathol"},{"key":"R27-20260316","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41379-018-0145-0","article-title":"Histiocyte-rich rhabdomyoblastic tumor: rhabdomyosarcoma, rhabdomyoma, or rhabdomyoblastic tumor of uncertain malignant potential? A histologically distinctive rhabdomyoblastic tumor in search of a place in the classification of skeletal muscle neoplasms","volume":"32","author":"Martinez","year":"2019","journal-title":"Mod Pathol"},{"key":"R28-20260316","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41379-020-00703-8","article-title":"\u201cInflammatory Leiomyosarcoma\u201d and \u201cHistiocyte-rich Rhabdomyoblastic Tumor\u201d: a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as \u201cinflammatory rhabdomyoblastic tumor","volume":"34","author":"Cloutier","year":"2021","journal-title":"Mod Pathol"},{"key":"R29-20260316","doi-asserted-by":"crossref","first-page":"100359","DOI":"10.1016\/j.modpat.2023.100359","article-title":"Inflammatory rhabdomyoblastic tumor: clinicopathologic and molecular analysis of 13 cases","volume":"37","author":"Odate","year":"2024","journal-title":"Mod Pathol"},{"key":"R30-20260316","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2559.2002.01418.x","article-title":"Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases","volume":"41","author":"Pileri","year":"2002","journal-title":"Histopathology"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T05:00:47Z","timestamp":1773637247000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002509"}},"subtitle":["Clinicopathologic and Molecular Analysis of 3 Cases"],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002509","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"2025-11-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}